Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With (131)I-Metaiodobenzylguanidine (MIBG)

BACKGROUND. (131)I-metaiodobenzylguanidine ((131)I-MIBG) is a targeted radiopharmaceutical for patients with neuroblastoma. Despite its tumor-specific uptake, the treatment with (131)I-MIBG results in whole-body radiation exposure. Our aim was to correlate whole-body radiation dose (WBD) from (131)I...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pediatr Blood Cancer
Hoofdauteurs: Trieu, Megan, DuBois, Steven G., Pon, Elizabeth, Nardo, Lorenzo, Hawkins, Randall A., Marachelian, Araz, Twist, Clare J., Park, Julie R., Matthay, Katherine K.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523914/
https://ncbi.nlm.nih.gov/pubmed/26506090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25816
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items